PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
Neusoft Selected in KPMG Chinese Rehabilitation and Elderly Care 50 List
SHENYANG, China , July 16, 2026 /PRNewswire/ -- Recently, KPMG Chinese Rehabilitation and Elderly Care 50 List Release and Awards Ceremony was held in Shanghai, China. Neusoft Corporation (SSE:600718) ...
2026-07-16T    Computer Networks   Computer Software   Computer/Electronics   Health Care/Hospital 
SCIE Study Shows HILO WAVE® Promotes Regenerative Skin Remodeling Without Inflammatory Response
Peer-reviewed preclinical findings validate the regenerative mechanism of HILO WAVE®'s proprietary Dual-HA Technology (DHC®). ...
2026-07-16T    Health Care/Hospital   Household/Consumer/Cosmetics 
Angel Yeast Showcases Sustainable Protein Innovation at the Growth Asia Summit 2026
SHANGHAI , July 16, 2026 /PRNewswire/ -- Angel Yeast (SSE: 600298) showcased its latest yeast protein innovations at the Growth Asia Summit 2026 in Singapore, held from July 8 to 10. On the ...
2026-07-16T    Biotechnology   Food/Beverages   Health Care/Hospital 
Novonesis and TurtleTree enter partnership to support commercialization of lactoferrin
COPENHAGEN, Denmark , July 16, 2026 /PRNewswire/ -- Novonesis, a global leader in biosolutions, today announced an agreement with TurtleTree, an innovator in precision fermented ingredients, and the ...
2026-07-16T    Biotechnology   Health Care/Hospital   Retail 
Clinicians Are Adopting AI to Solve the Documentation Crisis, New Global Survey Finds
New report finds 83% of clinicians adopted AI while workplace guidance and governance frameworks were still being developed. ...
2026-07-16T    Health Care/Hospital 
Telix Opens Australian-First Facility to Accelerate Delivery of New Cancer Treatments and Expand Sovereign Manufacturing
First-of-its-kind facility in Australia where radiopharmaceuticals are developed, manufactured and administered to patients under one roof. Patient care and research delivered in collaboration with ...
2026-07-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
First patients dosed in OPTIMAL-e [1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier ...
2026-07-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
HAIKOU, China , July 16, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals ...
2026-07-16T    Banking/Financial Service   Health Care/Hospital   Medical/Pharmaceuticals 
Metabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome Research
Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health, nutrition, disease, and treatment response ...
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing
Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases, while bacteria-only testing may miss viral co-detections in 88% of cases positive for pneumonia-associated ...
2026-07-15T    Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.